Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study.
Saved in:
| Title: | Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study. |
|---|---|
| Authors: | Roncaglia E; Computational Genomics Group, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.; Department of Biology, University of Padua, Padova, Italy., Gaffo E; Department of Molecular Medicine, University of Padua, Padova, Italy., Calabretto G; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy., Fürstenau M; Department I of Internal Medicine, University of Cologne, Cologne, Germany., Rogers KA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Baliakas P; Department of Immunology, Genetics and Pathology & Clinical Genomics Uppsala, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Cui C; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Institutes of Health Science, Tianjin, China., Miller C; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Plevova K; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno & Faculty of Medicine, Masaryk University, Brno, Czech Republic., Oscier D; Molecular Pathology, University Hospitals Dorset, Royal Bournemouth Hospital, Bournemouth, UK., Davis Z; Molecular Pathology, University Hospitals Dorset, Royal Bournemouth Hospital, Bournemouth, UK., Nguyen-Khac F; Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Paris, France., Rigolin GM; Hematology Section, Department of Medical Sciences, Arcispedale S. Anna, Azienda Ospedaliera-Universitaria, University of Ferrara, Ferrara, Italy., Athanasiadou A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Baran-Marszak F; Laboratoire d'hématologie, Hôpital Avicenne, Assistance Publique- Hôpitaux de Paris, Paris, France., Valiente A; Servicio de Genética, Hospital Universitario de Navarra, Pamplona, Spain., Terol MJ; Servicio de Hematología y Oncología Médica, Hospital Clinico Universitario de Valencia, Valencia, Spain., Abrisqueta P; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Espinet B; Molecular Cytogenetics Laboratory, Pathology Department, Translational Research on Hematological Neoplasms Group, Cancer Research Program, Hospital del Mar, Hospital del Mar Research Institute, Barcelona, Spain., Puiggros A; Molecular Cytogenetics Laboratory, Pathology Department, Translational Research on Hematological Neoplasms Group, Cancer Research Program, Hospital del Mar, Hospital del Mar Research Institute, Barcelona, Spain., Martines A; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padova, Italy., Bonaldi L; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padova, Italy., Mauro FR; Department of Translational and Precision Medicine, Hematology Unit, 'Sapienza' University, Rome, Italy., Scarfò L; Medical School, Università Vita-Salute San Raffaele, Milano, Italy.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milano, Italy., Chatzikonstantinou T; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Tausch E; Ulm University, Ulm, Germany., Kreuzer KA; Department I of Internal Medicine, University of Cologne, Cologne, Germany., Kater A; Department of Hematology, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands., Bosch F; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Doubek M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno & Faculty of Medicine, Masaryk University, Brno, Czech Republic., Panagiotidis P; First Department of Propaedeutic, University of Athens, Athens, Greece., Kalashnikova O; Federal State Budgetary Educational Institution of Higher Education Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of Russian Federation, St. Petersburg, Russia., Frezzato F; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy., Ruocco V; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy., Orsi S; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy., Salek K; Department of Molecular Medicine, University of Padua, Padova, Italy., Merlo R; Computational Genomics Group, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.; Department of Biology, University of Padua, Padova, Italy., Caregari A; Computational Genomics Group, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.; Department of Biology, University of Padua, Padova, Italy., Glogovitis I; Department of Molecular Medicine, University of Padua, Padova, Italy., Cellini A; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy., Angotzi F; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy., Serafin A; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy., Yi S; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Institutes of Health Science, Tianjin, China., Eichhorst B; Department I of Internal Medicine, University of Cologne, Cologne, Germany., Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Cuneo A; Hematology Section, Department of Medical Sciences, Arcispedale S. Anna, Azienda Ospedaliera-Universitaria, University of Ferrara, Ferrara, Italy., Ghia P; Medical School, Università Vita-Salute San Raffaele, Milano, Italy.; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milano, Italy., Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Trentin L; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy., Visentin A; Hematology Unit, Department of Medicine, University of Padua, via N Giustiniani 2, 35128, Padova, Italy. andrea.visentin@unipd.it., Bortoluzzi S; Computational Genomics Group, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy. |
| Source: | Journal of hematology & oncology [J Hematol Oncol] 2025 Jul 22; Vol. 18 (1), pp. 74. Date of Electronic Publication: 2025 Jul 22. |
| Publication Type: | Journal Article; Letter |
| Journal Info: | Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1756-8722 |
|---|---|
| DOI: | 10.1186/s13045-025-01725-y |
